Marchex Narrows H1 Loss, Posts Q2 Profit Amid Revenue Dip

TL;DR

**MCHX is showing signs of turning the corner with a Q2 profit, but watch that customer concentration like a hawk – it's a ticking time bomb.**

AI Summary

Marchex, Inc. reported a net income of $85 thousand for the three months ended June 30, 2025, a significant improvement from a net loss of $756 thousand in the prior-year period. However, for the six months ended June 30, 2025, the company posted a net loss of $1.897 million, though this was an improvement from a net loss of $2.206 million in the same period of 2024. Revenue slightly decreased to $11.655 million for the quarter, down from $12.074 million year-over-year, and to $23.058 million for the six-month period, down from $23.646 million. Operating expenses saw a reduction to $12.191 million for the quarter from $12.796 million, primarily due to lower product development costs, which fell from $3.223 million to $2.501 million. The company's cash and cash equivalents decreased to $10.491 million as of June 30, 2025, from $12.767 million at December 31, 2024. A new share repurchase program for up to 3,000,000 shares of Class B common stock was authorized in May 2025, replacing prior programs, though no repurchases have been made under it. The company continues to rely on a single customer, 'Customer A,' which accounted for 11% of consolidated revenue and 21% of consolidated accounts receivable as of June 30, 2025.

Why It Matters

Marchex's ability to achieve a net income in Q2 2025, despite a slight revenue decline, suggests improved operational efficiency, particularly in product development. This could signal a positive shift for investors, indicating the company is better managing its cost structure in a competitive AI-powered conversational analytics market. However, the continued significant revenue and accounts receivable concentration with 'Customer A' and an 'independent dealer network' poses a substantial competitive risk, as the loss of these key relationships could severely impact financial performance. Employees might see this as a sign of stabilization, while customers could benefit from a more focused and efficient service delivery.

Risk Assessment

Risk Level: medium — The company has a significant concentration risk, with 'Customer A' representing 11% of consolidated revenue and 21% of consolidated accounts receivable as of June 30, 2025. Additionally, an 'independent dealer network A' accounts for 14% of outstanding receivables. This reliance on a few key customers makes Marchex vulnerable to changes in their business or relationships.

Analyst Insight

Investors should monitor Marchex's progress in diversifying its customer base and revenue streams. While the Q2 net income is a positive sign, the high customer concentration warrants caution; consider a small, speculative position if you believe in their AI strategy, but be prepared for volatility.

Financial Highlights

debt To Equity

0.31

revenue

$11.655 million

operating Margin

-4.6%

total Assets

$41.984 million

total Debt

$9.941 million

net Income

$85 thousand

eps

N/A

gross Margin

65.0%

cash Position

$10.491 million

revenue Growth

-3.5%

Key Numbers

• $85 thousand — Net income (for the three months ended June 30, 2025, compared to a net loss of $756 thousand in Q2 2024)
• $1.897 million — Net loss (for the six months ended June 30, 2025, an improvement from $2.206 million in H1 2024)
• $11.655 million — Revenue (for the three months ended June 30, 2025, down from $12.074 million in Q2 2024)
• $23.058 million — Revenue (for the six months ended June 30, 2025, down from $23.646 million in H1 2024)
• $10.491 million — Cash and cash equivalents (as of June 30, 2025, a decrease from $12.767 million at December 31, 2024)
• 11% — Revenue concentration (from 'Customer A' for the three and six months ended June 30, 2025)
• 21% — Accounts receivable concentration (from 'Customer A' as of June 30, 2025)
• 3,000,000 shares — Share repurchase authorization (for Class B common stock under the new 2025 Repurchase Program)
• $2.501 million — Product development expense (for the three months ended June 30, 2025, down from $3.223 million in Q2 2024)
• $626 thousand — Interest income (expense) and other, net (for the three months ended June 30, 2025, a significant increase from $(31) thousand in Q2 2024)

Key Players & Entities

• Marchex, Inc. (company) — registrant
• Edwin Miller (person) — Chief Executive Officer and chief operating decision maker
• Customer A (company) — single customer representing significant revenue and receivables
• NASDAQ Global Select Market (regulator) — exchange where Class B Common Stock is registered
• SEC (regulator) — Securities and Exchange Commission
• FASB (regulator) — Financial Accounting Standards Board
• Delaware (regulator) — state of incorporation
• AI (company) — core technology for conversational intelligence
• Bloomberg (company) — financial news outlet

FAQ

Risk Factors

• Customer Concentration Risk [high — financial]: Marchex relies heavily on a single customer, 'Customer A,' which accounted for 11% of consolidated revenue and 21% of consolidated accounts receivable as of June 30, 2025. A significant reduction in business or termination of the relationship with this customer could materially and adversely affect the company's financial condition and results of operations.
• Dependence on Key Personnel [medium — operational]: The company's success depends on the continued service of its key management and technical personnel. The loss of any of these individuals could disrupt operations and negatively impact the company's ability to execute its business strategy.
• Intense Competition [medium — market]: The market for Marchex's services is highly competitive, with numerous companies offering similar solutions. Increased competition could lead to pricing pressures, reduced market share, and lower profitability.
• Technology and Product Development [medium — operational]: Marchex's ability to innovate and adapt its technology is crucial. A failure to keep pace with technological advancements or to develop new and improved products could render its offerings less competitive.

Industry Context

Marchex operates in the advertising technology and analytics sector, specifically focusing on call analytics for businesses. This industry is characterized by rapid technological advancements, increasing demand for data-driven insights, and intense competition from both established players and emerging startups. Trends include the growing importance of AI and machine learning in analyzing customer interactions and the shift towards performance-based advertising models.

Regulatory Implications

While Marchex's 10-Q does not highlight specific regulatory challenges, companies in the data analytics and advertising space are subject to evolving data privacy regulations (e.g., GDPR, CCPA) that could impact data collection and usage. Compliance with these regulations is crucial to avoid fines and maintain customer trust.

What Investors Should Do

1. [object Object]
2. [object Object]
3. [object Object]
4. [object Object]

Key Dates

• 2025-06-30: End of Q2 2025 — Reported net income of $85 thousand on $11.655 million revenue, showing sequential improvement but a year-over-year revenue decline.
• 2025-05-01: New Share Repurchase Program Authorized — Authorized repurchase of up to 3,000,000 shares of Class B common stock, indicating management's confidence or a strategy to return value to shareholders, though no repurchases have occurred yet.
• 2025-01-01: Start of H1 2025 — The six-month period ended with a net loss of $1.897 million, an improvement from the prior year, on revenue of $23.058 million.

Glossary

Accumulated deficit

The cumulative net losses of a company since its inception, minus any net gains. It represents a negative retained earnings balance. (Marchex has an accumulated deficit of $328.075 million as of June 30, 2025, indicating the company has historically incurred more losses than profits.)

Right-of-use lease assets

Assets recognized under accounting standards (like ASC 842) representing a lessee's right to use an identified asset for a period of time. (Marchex has $827 thousand in right-of-use lease assets as of June 30, 2025, reflecting its obligations under operating leases.)

Goodwill

An intangible asset that arises when a company acquires another company for a price greater than the fair value of its net assets. (Marchex has $17.558 million in goodwill, likely from past acquisitions, which is a significant portion of its total assets.)

Deferred revenue

Revenue that has been received by a company but not yet earned, as the goods or services have not been delivered or performed. (Marchex had $806 thousand in deferred revenue as of June 30, 2025, representing future revenue obligations.)

Year-Over-Year Comparison

Compared to the prior year's comparable periods, Marchex has shown a notable improvement in profitability, swinging from a net loss of $756 thousand to a net income of $85 thousand in Q2 2025, and reducing the net loss for the six-month period from $2.206 million to $1.897 million. However, this profitability improvement occurred alongside a slight decrease in revenue for both the quarter ($11.655M vs $12.074M) and the six-month period ($23.058M vs $23.646M). Operating expenses were also reduced, primarily driven by lower product development costs, contributing to the improved net income.

Key Financial Figures

• $0.01 — hich registered Class B Common Stock, $0.01 par value per share MCHX The NASDAQ

Filing Documents

• mchx-20250630.htm (10-Q) — 1967KB
• mchx-ex31_1.htm (EX-31.1) — 14KB
• mchx-ex31_2.htm (EX-31.2) — 16KB
• mchx-ex32.htm (EX-32) — 18KB
• 0001224133-25-000008.txt ( ) — 8176KB
• mchx-20250630.xsd (EX-101.SCH) — 930KB
• mchx-20250630_htm.xml (XML) — 1792KB

Notes to Consolidated Financial Statements (Unaudited)

Notes to Consolidated Financial Statements (Unaudited) 5 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 15 Item 3.

Quantitative and Qualitative Disclosures about Market Risk

Quantitative and Qualitative Disclosures about Market Risk 21 Item 4.

Controls and Procedures

Controls and Procedures 21 PART II. OTHER INFORMATION 22 Item 1.

Legal Proceedings

Legal Proceedings 22 Item 1A.

Risk Factors

Risk Factors 22 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 35 Item 4. Mine Safety Disclosures 35 Item 5. Other Information 35 Item 6. Exhibits 36 Signature 37 Table of Contents

—FINANCIAL INFORMATION

PART I—FINANCIAL INFORMATION

Consolidated Financial Statements

Item 1. Consolidated Financial Statements MARCHEX, INC. AND SUBSIDIARIES Consolida ted Balance Sheets (In Thousands) (Unaudited) June 30, December 31, 2025 2024 Assets Current assets: Cash and cash equivalents $ 10,491 $ 12,767 Accounts receivable, net 7,561 7,072 Prepaid expenses and other current assets 3,043 2,439 Total current assets 21,095 22,278 Property and equipment, net 1,736 1,811 Other assets, net 768 397 Right-of-use lease assets 827 1,156 Goodwill 17,558 17,558 Total assets $ 41,984 $ 43,200 Liabilities and Stockholders' Equity Current liabilities: Accounts payable $ 2,920 $ 1,349 Accrued benefits and payroll 992 2,133 Other accrued expenses and current liabilities 3,684 4,197 Deferred revenue and deposits 806 1,093 Operating lease liability, current 330 495 Total current liabilities 8,732 9,267 Deferred tax liabilities 658 579 Operating lease liability, non-current 551 721 Total liabilities $ 9,941 $ 10,567 Commitments and contingencies - See Note 10 Stockholders' equity: Common stock, $ 0.01 par value; Authorized 137,500 shares Class A: 12,500 shares authorized; 4,661 shares issued and outstanding at June 30, 2025 and December 31, 2024 49 49 Class B: 125,000 shares authorized; 39,247 shares issued and outstanding at June 30, 2025, including 150 shares of restricted stock; and 39,025 shares issued and outstanding at December 31, 2024, including 365 shares of restricted stock 393 390 Additional paid-in capital 359,676 358,372 Accumulated deficit ( 328,075 ) ( 326,178 ) Total stockholders' equity 32,043 32,633 Total liabilities and stockholders' equity $ 41,984 $ 43,200 See accompanying Notes to the Consolidated Financial Statements. 1 Table of Contents MARCHEX, INC. AND SUBSIDIARIES Consolidated S tatements of Operations (In Thousands, except